QuantLogix ← CRL scorecard
📅 CRL Earnings Preview
CRL
Next report (est.)
11/04/2026
Countdown
8 days
EPS growth YoY
-102.8%
Revenue growth YoY
-2.7%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/05/2026 ±3.4% +11.4% under-priced
05/07/2026 ±4.4% -0.0% over-priced
02/18/2026 ±7.4% -0.3% over-priced
11/05/2025 ±3.9% -5.7% under-priced
08/06/2025 ±3.4% -10.3% under-priced
05/07/2025 ±4.3% +18.7% under-priced
02/19/2025 ±2.7% +6.9% under-priced
11/06/2024 ±3.3% +13.5% under-priced
Across these reports, options implied an average ±4.1% move vs an actual average of 8.3% — the stock stayed inside the implied band 25% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $-0.03 $1.0B $-1M
Q1 FY2026 $-0.30 $996M $-15M
Q4 FY2025 — $994M $-277M
Q3 FY2025 $1.10 $1.0B $54M
Analyst posture
Buy / Strong Buy
18
Hold
5
Sell
0
Strong upward revisions — 25 net (vs 23 prior)
Live 5-factor engine read: Buy · 86/100 Full scorecard →
Get alerted before every CRL report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CRL before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

CRL (CRL) reports in 8 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±4.1% earnings move while the stock actually moved 8.3% on average — the market has tended to under-price CRL's earnings risk. Fundamentals into the print: EPS down 102.8% year-over-year, revenue down 2.7%. QuantLogix's live 5-factor engine currently reads CRL as a buy at 86/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →